biomarker

Deals, joint ventures & alliances

Biolidics collaborates with Hangzhou Normal University to undertake clinical investigations for lung cancer biomarker

SINGAPORE (Sept 9): Biolidics, the medical technology company, is collaborating with Hangzhou Normal University to undertake clinical investigations to validate the clinical utility of CTCs as a biomarker in late stage lung cancer.
×